Susvimo Prices, Coupons, Copay Cards & Patient Assistance
Susvimo (ranibizumab ophthalmic) is a member of the anti-angiogenic ophthalmic agents drug class and is commonly used for Diabetic Macular Edema, and Macular Degeneration.
The cost for Susvimo (100 mg/mL) intravitreal solution is around $8,550 for a supply of 0.1 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Susvimo prices
Intravitreal Solution
100 mg/mL
Susvimo intravitreal solution
from $8,550.16
for 0.1 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 0.1 milliliters | $85,501.60 | $8,550.16 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Susvimo Coupons, Copay Cards and Rebates
Susvimo offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Susvimo Genentech Ophthalmology Co-pay Program
Eligible commercially insured patients may pay $0 on out-of-pocket costs per treatment.
- Applies to:
- Susvimo
- Number of uses:
- Per prescription per calendar year
Form more information phone: 855-218-5307 or Visit website
Susvimo Genentech Ophthalmology Co-pay Program Rebate
Eligible commercially insured patients may request a rebate if they paid their provider directly for treatment.
- Applies to:
- Susvimo
- Number of uses:
- One rebate per prescription fill
Form more information phone: 855-218-5307 or Visit website
Patient Assistance & Copay Programs for Susvimo
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Susvimo (ranobizumab) Implant; Ocular
More information please phone: 866-316-7263 Visit Website
Provider: Genentech Patient Foundation
Eligibility requirements:- Uninsured or Underinsured with no prescription coverage for needed medication
- Based on FPL
- Medically appropriate condition/diagnosis
- Must be treated by US licensed healthcare provider
- The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- Susvimo (ranobizumab) Implant; Ocular
More information please phone: 888-941-3331 or 866-422-2377 Visit Website
Provider: Genentech Opthamology Access Solutions
Eligibility requirements:- Determined case by case
- Based on FPL
- Medically appropriate condition/diagnosis
- Must be treated by US licensed healthcare provider
- Eligibility determined on a case-by-case basis. Contact program for details.
- Susvimo (ranobizumab) Implant; Ocular
More information please phone: 833-393-4363 or 866-422-2377 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Syfovre
Syfovre (pegcetacoplan) treatment for geographic atrophy (GA) a form of dry age-related macular ...
Eylea
Eylea is used to treat neovascular (wet) age-related macular degeneration (AMD), macular edema ...
Izervay
Izervay (avacincaptad pegol) is used for treating geographic atrophy (GA) due to age-related ...
Vabysmo
Vabysmo eye injection is used to treat eye diseases neovascular (wet) age-related macular ...
Ozurdex
Ozurdex is an implant injected into the eye to treat swelling that may occur when there is a ...
Lucentis
Lucentis is used to treat the wet form of age-related macular degeneration. Learn about side ...
Byooviz
Byooviz injection is used to treat types of macular degeneration, macular edema and mCNV. Byooviz ...
Maxidex
Maxidex is used for conjunctivitis, conjunctivitis, allergic, cyclitis, iritis, keratitis, macular ...
Pavblu
Pavblu (aflibercept-ayyh) is a biosimilar to Eylea that may be used to treat the following eye ...
More about Susvimo (ranibizumab ophthalmic)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
